Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 01 October 2026
      Overweight and obesity linked to 278,000 deaths and the loss of 8 million years of healthy life in 8 European countries
 
 
Read the full report.
 

A new study across eight countries in Europe shows that elevated body mass index (BMI) is linked to major health and economic costs each year. 

With 56% of people in Europe being overweight or living with obesity - including a third of all children - the health and financial impact of these conditions on European countries is starkly laid out in a new report commissioned by EFPIA. The Economic Burden of Overweight and Obesity in Europe  by the Office for Health Economics (OHE) quantifies the health and economic burden associated with overweight and obesity across eight European countries - Germany, France, Italy, Spain, Ireland, Greece, Romania and the United Kingdom.  

Read more →
 
 
      We keep track of our steps, calories and screen time. But do we know the numbers that matter for our cardiovascular health?

Earlier this week, the European Commission published its proposal for a Council Recommendation on cardiovascular health checks. As the Council negotiates this Recommendation, Member States have an opportunity to put in place policies which could save millions of lives, ensure health system resilience and support wider European economies and societies. The Recommendation put forward is bold and ambitious. If implemented in full it will prevent many future cardiometabolic conditions and reduce inequalities in and between Member States.  

Early detection and screening are critical for keeping European citizens healthier for longer. We would ask Member States to preserve and build on the proposal’s strongest elements. This includes health checks in primary care settings, offering opportunistic health checks and the provision of appropriate follow-up treatment and care for all patients. 

Read our statement here.

 
 
      Putting people at the heart of Alzheimer’s journey

Watch our video series and read the blog to explore perspectives from across the dementia community.

 
 
 
 
Rethinking dementia: Voices on care, connection and innovation
 
 
Speeding up Alzheimer's diagnosis: Widening the screening bottleneck
 
 
 
 
      Events
 
 
14 OCT 2026
  From medicines shortages to medicines security: Building a more resilient European... Brussels, Belgium

Bringing together stakeholders from across the healthcare value chain, this HCI event will explore how Europe can strengthen...

Learn more →
 
 
 
15 OCT 2026
  From EU ambition to national action: Strengthening Cardiovascular Health Plans across... Brussels, Belgium

Organised by the EFPIA Cardiovascular Health Platform and IPHA, this event will explore how the EU Safe Hearts Plan...

Learn more →
 
 
      What we are reading
EU falling behind US, China pharma industry warns 01 October 2026  (Rapporteur) Read more →
How are IMI & Innovative Health Initiative (IHI) projects helping to transform cardiovascular... 30 September 2026  (IHI) Read more →
Beyond childhood: why lifelong vaccination is a frontline defence against chronic disease 08 September 2026  (Vaccines Today) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe